Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic
Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Since the onset of the COVID-19 pandemic, there have been concerns over the mental health impact of COVID-19. This is a review of the utilization of antidepressants, anxiolytics, and hypnotics since the COVID-19 pandemic was declared on March the 11th 2020. A number of reports so far have been based on large prescription databases for administrativ...
Alternative Titles
Full title
Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6a13d1a367ec49cda575479e19eee33e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6a13d1a367ec49cda575479e19eee33e
Other Identifiers
ISSN
2158-3188
E-ISSN
2158-3188
DOI
10.1038/s41398-024-02894-z
